Generation of synthetic nanobodies against delicate proteins.

Zimmermann, Iwan; Egloff, Pascal; Hutter, Cedric A J; Kuhn, Benedikt T; Bräuer, Philipp; Newstead, Simon; Dawson, Roger J P; Geertsma, Eric R; Seeger, Markus A

Zimmermann, Iwan; Egloff, Pascal; Hutter, Cedric A J; Kuhn, Benedikt T; Bräuer, Philipp; Newstead, Simon; Dawson, Roger J P; Geertsma, Eric R; Seeger, Markus A.

Afiliação

Zimmermann I; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Egloff P; Linkster Therapeutics AG, Zurich, Switzerland.
Hutter CAJ; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Kuhn BT; Linkster Therapeutics AG, Zurich, Switzerland.
Bräuer P; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Newstead S; Institute of Biochemistry, Goethe University Frankfurt, Frankfurt am Main, Germany.
Dawson RJP; Department of Biochemistry, University of Oxford, Oxford, UK.
Geertsma ER; Department of Biochemistry, University of Oxford, Oxford, UK.
Seeger MA; Linkster Therapeutics AG, Zurich, Switzerland.

Nat Protoc ; 15(5): 1707-1741, 2020 05.

Article em En | MEDLINE | ID: mdl-32269381

Assuntos

Técnicas de Química Sintética/métodos; Anticorpos de Domínio Único/química; Bacteriófagos/química; Ribossomos/química

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Química Sintética / Anticorpos de Domínio Único Tipo de estudo: Evaluation_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google